Bibliographic details
Picot J, Cooper K, Bryant J, Clegg A. The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation. Health Technology Assessment 2011; 15(41): 1-204
MeSH
Adrenal Cortex Hormones /economics /therapeutic use; Alkylating Agents /administration & Antineoplastic Combined Chemotherapy Protocols /economics /therapeutic use; Boronic Acids /economics /therapeutic use; Bortezomib; Cost-Benefit Analysis; Cyclophosphamide /economics /therapeutic use; Humans; Immunosuppressive Agents /administration & Melphalan /economics /therapeutic use; Multiple Myeloma /drug therapy; Pyrazines /economics /therapeutic use; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Survival Analysis; Thalidomide /economics /therapeutic use; dosage /economics /therapeutic use; dosage /economics /therapeutic use